Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
3.730
-0.080 (-2.10%)
At close: Jul 24, 2025, 4:00 PM
3.800
+0.070 (1.88%)
After-hours: Jul 24, 2025, 7:38 PM EDT

Eledon Pharmaceuticals Stock Forecast

Stock Price Forecast

The 2 analysts that cover Eledon Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $12.5, which forecasts a 235.12% increase in the stock price over the next year. The lowest target is $9 and the highest is $16.

Price Target: $12.5 (+235.12%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$9.00$12.5$16$16
Change+141.29%+235.12%+328.95%+328.95%
* Price targets were last updated on Jun 18, 2025.

Analyst Ratings

The average analyst rating for Eledon Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy111122
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total111122

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$9
Strong BuyInitiates$9+141.29%Jun 18, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$16
Strong BuyReiterates$16+328.95%Nov 20, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$16
Strong BuyReiterates$16+328.95%Jun 4, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$16
Strong BuyReiterates$16+328.95%May 10, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$13$16
Strong BuyMaintains$13$16+328.95%May 7, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 53.04M
Revenue Next Year
n/a
EPS This Year
-0.92
from -0.75
EPS Next Year
-1.02
from -0.92
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027FY 2028FY 2029
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027Dec 31, 2028Dec 31, 2029
Revenue
---4.44M53.04M
Revenue Growth
----1,095.40%---
EPS
-15.72-2.33-6.16-4.73-0.75-0.92-1.02-1.16
EPS Growth
--------
Forward PE
--------
No. Analysts
-----664
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
Highn/an/an/a
Avgn/an/an/a
Lown/an/an/a

Revenue Growth

Revenue Growth20252026202720282029
High---
Avg---
Low---

EPS Forecast

EPS20252026202720282029
High-0.77-0.76-1.08
Avg-0.92-1.02-1.16
Low-1.00-1.18-1.23

EPS Growth

EPS Growth20252026202720282029
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.